Iron Gate Global Advisors’s GSK GSK Stock Holding History

Iron Gate Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Hold	5,429	–	–	0.03%	86
2026 Q1	$300K	Buy	+5,429	New	+$294K	0.03%	78
2020 Q3	–	Sell	-4,091	Closed	-$209K	–	103
2020 Q2	$209K	Buy	+4,091	New	+$210K	0.1%	79
2020 Q1	–	Sell	-3,680	Closed	-$216K	–	59
2019 Q4	$216K	Buy	+3,680	New	+$205K	0.12%	59
2018 Q4	–	Sell	-3,200	Closed	-$161K	–	136
2018 Q3	$161K	Sell	3,200 -640	-17%	-$32.5K	0.1%	67
2018 Q2	$193K	Buy	+3,840	New	+$193K	0.14%	48
2018 Q1	–	Sell	-3,200	Closed	-$141K	–	60
2017 Q4	$141K	Buy	+3,200	New	+$148K	0.12%	47

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Iron Gate Global Advisors's GSK Position: Q2 2026 in Review

Iron Gate Global Advisors held its GSK (GSK) position steady in Q2 2026 at 5,429 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #86.

Iron Gate Global Advisors first reported a position in GSK in Q4 2017 and has held it in 7 quarters since. The position peaked at $300K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Iron Gate Global Advisors held 5,429 shares of GSK worth $285K as of Q2 2026.
Iron Gate Global Advisors left its GSK share count unchanged in Q2 2026.
GSK made up 0.03% of Iron Gate Global Advisors's portfolio in Q2 2026, its #86 holding.
Iron Gate Global Advisors first reported a position in GSK in Q4 2017 and has held it in 7 quarters since.
Iron Gate Global Advisors's GSK position peaked at $300K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Iron Gate Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.